Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 18

1.

Preclinical evaluation of anti-HER2 Affibody molecules site-specifically labeled with 111In using a maleimido derivative of NODAGA.

Altai M, Perols A, Karlström AE, Sandström M, Boschetti F, Orlova A, Tolmachev V.

Nucl Med Biol. 2012 May;39(4):518-29. doi: 10.1016/j.nucmedbio.2011.10.013. Epub 2011 Dec 14.

PMID:
22172396
[PubMed - indexed for MEDLINE]
2.

Evaluation of maleimide derivative of DOTA for site-specific labeling of recombinant affibody molecules.

Ahlgren S, Orlova A, Rosik D, Sandström M, Sjöberg A, Baastrup B, Widmark O, Fant G, Feldwisch J, Tolmachev V.

Bioconjug Chem. 2008 Jan;19(1):235-43. doi: 10.1021/bc700307y. Epub 2007 Dec 29.

PMID:
18163536
[PubMed - indexed for MEDLINE]
3.

Indium-111-labeled trastuzumab scintigraphy in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer.

Perik PJ, Lub-De Hooge MN, Gietema JA, van der Graaf WT, de Korte MA, Jonkman S, Kosterink JG, van Veldhuisen DJ, Sleijfer DT, Jager PL, de Vries EG.

J Clin Oncol. 2006 May 20;24(15):2276-82.

PMID:
16710024
[PubMed - indexed for MEDLINE]
Free Article
4.

Early tumor response to Hsp90 therapy using HER2 PET: comparison with 18F-FDG PET.

Smith-Jones PM, Solit D, Afroze F, Rosen N, Larson SM.

J Nucl Med. 2006 May;47(5):793-6.

PMID:
16644749
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Preclinical characterisation of 111In-DTPA-trastuzumab.

Lub-de Hooge MN, Kosterink JG, Perik PJ, Nijnuis H, Tran L, Bart J, Suurmeijer AJ, de Jong S, Jager PL, de Vries EG.

Br J Pharmacol. 2004 Sep;143(1):99-106. Epub 2004 Aug 2.

PMID:
15289297
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Imaging the pharmacodynamics of HER2 degradation in response to Hsp90 inhibitors.

Smith-Jones PM, Solit DB, Akhurst T, Afroze F, Rosen N, Larson SM.

Nat Biotechnol. 2004 Jun;22(6):701-6. Epub 2004 May 9.

PMID:
15133471
[PubMed - indexed for MEDLINE]
Free Article
7.

Developing inhibitors of the epidermal growth factor receptor for cancer treatment.

Grünwald V, Hidalgo M.

J Natl Cancer Inst. 2003 Jun 18;95(12):851-67. Review.

PMID:
12813169
[PubMed - indexed for MEDLINE]
Free Article
8.

Impact of epidermal growth factor receptor expression on survival and pattern of relapse in patients with advanced head and neck carcinoma.

Ang KK, Berkey BA, Tu X, Zhang HZ, Katz R, Hammond EH, Fu KK, Milas L.

Cancer Res. 2002 Dec 15;62(24):7350-6.

PMID:
12499279
[PubMed - indexed for MEDLINE]
Free Article
9.

A new and convenient method for purification of 86Y using a Sr(II) selective resin and comparison of biodistribution of 86Y and 111In labeled Herceptin.

Garmestani K, Milenic DE, Plascjak PS, Brechbiel MW.

Nucl Med Biol. 2002 Jul;29(5):599-606.

PMID:
12088731
[PubMed - indexed for MEDLINE]
10.

Biology of HER2 and its importance in breast cancer.

Yarden Y.

Oncology. 2001;61 Suppl 2:1-13. Review.

PMID:
11694782
[PubMed - indexed for MEDLINE]
11.

The EGFR family and its ligands in human cancer. signalling mechanisms and therapeutic opportunities.

Yarden Y.

Eur J Cancer. 2001 Sep;37 Suppl 4:S3-8. Review.

PMID:
11597398
[PubMed - indexed for MEDLINE]
12.

The basic biology of HER2.

Rubin I, Yarden Y.

Ann Oncol. 2001;12 Suppl 1:S3-8. Review.

PMID:
11521719
[PubMed - indexed for MEDLINE]
13.

Growth factor synthesis and human breast cancer progression.

Ethier SP.

J Natl Cancer Inst. 1995 Jul 5;87(13):964-73. Review.

PMID:
7629883
[PubMed - indexed for MEDLINE]
14.

Predictive value of EGF receptor in breast cancer.

Costa S, Stamm H, Almendral A, Ludwig H, Wyss R, Fabbro D, Ernst A, Takahashi A, Eppenberger U.

Lancet. 1988 Nov 26;2(8622):1258. No abstract available.

PMID:
2903994
[PubMed - indexed for MEDLINE]
15.

Expression of epidermal growth factor receptor in human gastric and colonic carcinomas.

Yasui W, Sumiyoshi H, Hata J, Kameda T, Ochiai A, Ito H, Tahara E.

Cancer Res. 1988 Jan 1;48(1):137-41.

PMID:
2446740
[PubMed - indexed for MEDLINE]
Free Article
16.

Anti-epidermal growth factor receptor monoclonal antibodies as potential anti-cancer agents.

Mendelsohn J.

J Steroid Biochem Mol Biol. 1990 Dec 20;37(6):889-92. Review.

PMID:
2285602
[PubMed - indexed for MEDLINE]
17.

Epidermal growth factor.

Carpenter G, Cohen S.

J Biol Chem. 1990 May 15;265(14):7709-12. Review. No abstract available.

PMID:
2186024
[PubMed - indexed for MEDLINE]
Free Article
18.

Humanization of an anti-p185HER2 antibody for human cancer therapy.

Carter P, Presta L, Gorman CM, Ridgway JB, Henner D, Wong WL, Rowland AM, Kotts C, Carver ME, Shepard HM.

Proc Natl Acad Sci U S A. 1992 May 15;89(10):4285-9.

PMID:
1350088
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk